• Citer

Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy.

par Marmolino, Daniele ;Acquaviva, Fabio
Référence Cerebellum, 8, 3, page (245-259)
Publication Publié, 2009-09

Article révisé par les pairs

• Détails
• Contenu

Titre:	Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy.
Auteur:	Marmolino, Daniele; Acquaviva, Fabio
Informations sur la publication:	Cerebellum, 8, 3, page (245-259)
Statut de publication:	Publié, 2009-09
Sujet CREF:	Neurologie
	Sciences bio-médicales et agricoles
Mots-clés:	Frataxin
	Friedreich's ataxia
	FXN gene
	GAA triplet repeat
	Neurodegeneration
MeSH keywords:	Animals
	Antioxidants -- pharmacology -- therapeutic use
	Chlorofluorocarbons, Methane -- pharmacology -- therapeutic use
	Enzyme Inhibitors -- pharmacology -- therapeutic use
	Friedreich Ataxia -- drug therapy -- genetics -- therapy
	Gene Silencing -- physiology
	Heterochromatin -- metabolism
	Histone Deacetylases -- metabolism
	Histones -- metabolism
	Humans
	Iron -- metabolism
	Iron Chelating Agents -- pharmacology -- therapeutic use
	Iron-Binding Proteins -- genetics
	Models, Biological
	PPAR gamma -- metabolism
	Signal Transduction -- drug effects
	Transcription Factors -- metabolism
	Trinucleotide Repeats -- genetics
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	Review
	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:1473-4222
	info:doi/10.1007/s12311-008-0084-2
	info:scp/68449096810
	info:pmid/19165552